Você procurou por: chanjo ya kuku (Suaíli - Inglês)

chanjo ya uviko-19
secretary general ministry of health

firigis ya kuku
firigis of the gombe

dawa ya minyoo ya kuku
chicken vaccines

makao ya kuku vifaranga?
makao ya kuku ni?

gizzard ya kuku kwa kiswahili
chicken gizzard in kiswahili

kadi ya kumbukumbu ya uchanjaji wa chanjo ya uviko-19
secretary general ministry of health

kwanza, watafiti wanakusudia kuunda chanjo ya virusi vyote.
first, researchers aim to build a whole virus vaccine.

hakuna chanjo ya covid-19, ingawa mashirika mengi wana shughulika kutengeneza moja.
there is no covid-19 vaccine, though many organizations are working to develop one.

virusi hivyo vinaweza kuenea kwa viungo tofauti ndani ya kuku.
the virus can spread to different organs throughout the chicken.

ikiwa wewe ni mzee au uko katika kundi lenye hatari ya juu na unaweza kupata chanjo ya nimonia, pata chanjo hiyo.
if you are elderly or otherwise in a high-risk group and can be vaccinated for pneumonia, get that vaccination.

kufikia 2020, hakuna tiba au chanjo ya kulinda dhidi ya sars ambazo zimeonyeshwa kuwa salama na kulera matokeo yanayotarajiwa kwa binadamu.
as of 2020, there is no cure or protective vaccine for sars that has been shown to be both safe and effective in humans.

mbinu ya tatu ni ya chanjo ya asidi ya kiini cha chembe (chanjo za dna au rna, mbinu mpya ya kutengeneza chanjo).
a third strategy is that of the nucleic acid vaccines (dna or rna vaccines, a novel technique for creating a vaccination).

mnamo 24 januari 2020 nchini australia, chuo kikuu cha queensland kilitangaza kwamba kinafanya uchunguzi wa uwezekano wa chanjo ya kunata molekuli inayoweza kubadilisha kijenetiki protini za virusi ili kuchochea kinga ya mwili.
around 24 january 2020 in australia, the university of queensland announced that it is investigating the potential of a molecular clamp vaccine that would genetically modify viral proteins in order to stimulate an immune reaction.

chanjo ya b'a covid-19 ni chanjo ya kubuni ya kuzuia ugonjwa wa virusi vya korona 2019 (covid-19).
b'a covid-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (covid-19).

huko italia tarehe 17 machi 2020, takis biotech, kampuni ya bioteknolojia ya italia ilitangaza kuwa watakuwa na matokeo vipimo kwa wanyama mwezi wa aprili 2020 na chanjo ya mwisho iliyoteuliwa inaweza kuanza kufanyiwa vipimo wakati wa majira ya kupuputika kwa majani.
in italy on 17 march 2020, takis biotech, an italian biotech company announced they will have pre-clinical testing results in april 2020 and their final vaccine candidate could begin human testing by fall.

chanjo hiyo ina msimbo wa jenitiki usio na madhara uliyonakiliwa kutoka kwa ugonjwa huo. uboreshaji unaotegemea kingamwili umependekezwa kama changamoto inayowezekana ya maendeleo ya chanjo ya sars-cov-2, lakini ina utata.
the vaccine contains a harmless genetic code copied from the virus that causes the disease.antibody dependent enhancement has been suggested as a potential challenge for vaccine development for sars-cov-2, but this is controversial.

haitakulinda dhidi ya nimonia ya virusi ya covid-19, lakini baadhi ya wagonjwa wa covid-19 wameaga dunia kutokana na nimonia ya bakteria ambayo ilishambulia mapafu yao dhahifu, kwa hivyo chanjo ya nimonia inaweza kuokoa maisha yako.
it won't protect you from viral pneumonia from covid-19, but some covid-19 patients have died of bacterial pneumonia that attacked their weakened lungs, so a pneumonia vaccination could save your life.

mapema juma lililopita, wakati wa uzinduzi wa mkutano juu ya chanjo ya ukimwi ya kimataifa ya 2008 (international aids vaccine 2008) huko cape town, hogan, alitangaza hadharani kwamba vvu husababisha ukimwi na kwamba ni lazima kukabiliana nao kwa kutumia dawa za hospitalini.
earlier this week, at the opening of the international aids vaccine 2008 conference in cape town, hogan publicly declared that hiv does cause aids and should be treated with conventional medicine.

hadi machi2020, kulikuwa na chanjo moja ya mers (inayotegemea dna) iliyokamilisha majaribio ya awamu ya i ya kliniki kwa wanadamu, na zingine tatu zinaendelea, zote ambazo ni chanjo ya kuzuia virusi, virusi viwili ya dna (chadox1-mers, bvrs-gamvac), na mva-vectored (mva-mers-s).
as of march 2020, there was one (dna based) mers vaccine which completed phase i clinical trials in humans, and three others in progress, all of which are viral-vectored vaccines, two adenoviral-vectored (chadox1-mers, bvrs-gamvac), and one mva-vectored (mva-mers-s).